Announce Date | 06/27/2024 |
EPS Normalized Actual | $1.01 (Beat by $0.172) |
EPS GAAP Actual | $1.01 (Beat by $0.172) |
Revenue Actual | $10.871B |
Revenue Surprise | Beat by $10871M |
Announce Date | 12/31/1969 (Pre-Market) |
EPS Normalized Estimate | $ |
EPS GAAP Estimate | $ |
Revenue Estimate | $0B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
May 2029 | 4.81 | 16.24 | 4.4624 | 5.03714 | 3 |
May 2028 | 5.52 | 14.15 | 5.33195 | 5.69275 | 11 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ1 2022 (Feb 2022) | 0.88 | 0.88 | 10.871B | 4.73% | 10871M |
FQ4 2021 (Nov 2021) | 0.84 | 0.84 | 11.357B | 1% | 11357M |
FQ3 2021 (Aug 2021) | 1.18 | 1.18 | 12.248B | 13.5% | 12248M |
FQ2 2021 (May 2021) | 0.96 | 0.96 | 12.344B | 48.86% | 12344M |
FQ1 2021 (Feb 2021) | 0.92 | 0.92 | 10.357B | 2.44% | 10357M |
FQ4 2020 (Nov 2020) | 0.8 | 0.8 | 11.243B | 8.16% | 11243M |
FQ3 2020 (Aug 2020) | 0.97 | 0.97 | 10.594B | -0.62% | 10594M |
FQ2 2020 (May 2020) | -0.51 | -0.51 | 6.313B | -61.32% | 6313M |
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ1 2027 (Mar 2027) | 1.11 | -- | 1.08138 | 1.1376 | 7 |
FQ4 2026 (Dec 2026) | 1.04 | -- | 1.01319 | 1.06586 | 9 |
FQ3 2026 (Aug 2026) | 0.69 | -- | 0.67221 | 0.70716 | 13 |
FQ2 2026 (May 2026) | 1.15 | -- | 1.12919 | 1.1659 | 12 |
FQ1 2026 (Mar 2026) | 1.145 | -- | 1.11525 | 1.16606 | 14 |
FQ4 2025 (Nov 2025) | 1.19 | -- | 1.16847 | 1.20645 | 7 |
FQ3 2025 (Aug 2025) | 1.02333 | -- | 1.00481 | 1.03748 | 7 |
FQ2 2025 (May 2025) | 0.98891 | -- | 0.97102 | 1.00258 | 7 |
FQ1 2025 (Mar 2025) | 0.93096 | -- | 0.90677 | 0.94808 | 9 |
FQ4 2024 (Nov 2024) | 1.18084 | -- | 1.15016 | 1.20255 | 10 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ1 2027 (Mar 2027) | 13.94B | -- | 13.66B | 14.2B | 8 |
FQ4 2026 (Dec 2026) | 14.39B | -- | 14.1B | 14.66B | 7 |
FQ3 2026 (Aug 2026) | 13.03B | -- | 12.78B | 13.28B | 7 |
FQ2 2026 (May 2026) | 14.52B | -- | 14.32B | 14.68B | 13 |
FQ1 2026 (Mar 2026) | 14B | -- | 13.72B | 14.2B | 9 |
FQ4 2025 (Nov 2025) | 14.16B | -- | 13.96B | 14.31B | 6 |
FQ3 2025 (Aug 2025) | 13.47B | -- | 13.28B | 13.61B | 6 |
FQ2 2025 (May 2025) | 13.53B | -- | 13.34B | 13.67B | 6 |
FQ1 2025 (Mar 2025) | 13.03B | -- | 12.77B | 13.21B | 11 |
FQ4 2024 (Nov 2024) | 14.16B | -- | 13.87B | 14.36B | 9 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
7
EPS # of Misses
1
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2022 (Feb 2022) | 0.88 | 0.88 | 100% | |
FQ4 2021 (Nov 2021) | 0.84 | 0.84 | 100% | |
FQ3 2021 (Aug 2021) | 1.18 | 1.18 | 100% | |
FQ2 2021 (May 2021) | 0.96 | 0.96 | 100% | |
FQ1 2021 (Feb 2021) | 0.92 | 0.92 | 100% | |
FQ4 2020 (Nov 2020) | 0.8 | 0.8 | 100% | |
FQ3 2020 (Aug 2020) | 0.97 | 0.97 | 100% | |
FQ2 2020 (May 2020) | -0.51 | -0.51 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2022 (Feb 2022) | $0B | $10.87B | $10871M | 100% |
FQ4 2021 (Nov 2021) | $0B | $11.36B | $11357M | 100% |
FQ3 2021 (Aug 2021) | $0B | $12.25B | $12248M | 100% |
FQ2 2021 (May 2021) | $0B | $12.34B | $12344M | 100% |
FQ1 2021 (Feb 2021) | $0B | $10.36B | $10357M | 100% |
FQ4 2020 (Nov 2020) | $0B | $11.24B | $11243M | 100% |
FQ3 2020 (Aug 2020) | $0B | $10.59B | $10594M | 100% |
FQ2 2020 (May 2020) | $0B | $6.31B | $6313M | 100% |